Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • CCC Cancer Update
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation
    Inhaltsbereich


    Zurück zur Übersicht
    Frontiers in neurology. 2019 Aug 2. doi: 10.3389/fneur.2019.00821. pmc: PMC6688052
    Newly Diagnosed and Growing Subependymal Giant Cell Astrocytoma in Adults With Tuberous Sclerosis Complex: Results From the International TOSCA Study.
    Jansen AC1,  Belousova E2,  Benedik MP3,  Carter T4,  Cottin V5,  Curatolo P6,  D'Amato L7,  Beaure d'Augères G8,  de Vries PJ9,  Ferreira JC10,  Feucht M11,  Fladrowski C12,  Hertzberg C13,  Jozwiak S14,  Lawson JA15,  Macaya A16,  Marques R17,  Nabbout R18,  O'Callaghan F19,  Qin J20,  Sander V21,  Sauter M22,  Shah S23,  Takahashi Y24,  Touraine R25,  Youroukos S26,  Zonnenberg B27,  Kingswood JC28
    Author information
    1Pediatric Neurology Unit, Department of Pediatrics, UZ Brussel VUB, Brussels, Belgium.
    2Research and Clinical Institute of Pediatrics, Pirogov Russian National Research Medical University, Moscow, Russia.
    3Child Neurology Department, SPS Pediatrična Klinika, Ljubljana, Slovenia.
    4Tuberous Sclerosis Association (TSA), Nottingham, United Kingdom.
    5Hôpital Louis Pradel, Claude Bernard University Lyon 1, Lyon, France.
    6Child Neurology and Psychiatry Unit, Systems Medicine Department, Tor Vergata University Hospital, Rome, Italy.
    7Novartis Farma S.p.A., Origgio, Italy.
    8Association Sclérose Tubéreuse de Bourneville, Gradignan, France.
    9Division of Child and Adolescent Psychiatry, University of Cape Town, Cape Town, South Africa.
    10Neurology Department, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal.
    11Medical University of Vienna, Universitätsklinik für Kinder-und Jugendheilkunde, Vienna, Austria.
    12Associazione Sclerosi Tuberosa ONLUS, Milan, Italy.
    13Zentrum für Neuropädiatrie und Sozialpädiatrie, Vivantes-Klinikum Neukölln, Berlin, Germany.
    14Department of Child Neurology, Warsaw Medical University, Warsaw, Poland.
    15The Tuberous Sclerosis Multidisciplinary Management Clinic, Sydney Children's Hospital, Randwick, NSW, Australia.
    16Pediatric Neurology Section, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
    17Novartis Farma S.p.A., Origgio, Italy.
    18Department of Pediatric Neurology, Necker Enfants Malades Hospital, Paris Descartes University, Paris, France.
    19Paediatric Neuroscience, Institute of Child Health, University College London, London, United Kingdom.
    20Department of Pediatrics, Peking University People's Hospital, Beijing, China.
    21Neurology and Rehabilitation, Tallinn Children Hospital, Tallinn, Estonia.
    22Klinikum Kempten, Klinikverbund Kempten-Oberallgäu gGmbH, Kempten, Germany.
    23Novartis Healthcare Pvt Ltd., Hyderabad, India.
    24National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, NHO, Aoi-ku, Japan.
    25Department of Genetics, CHU-Hôpital Nord, Saint Etienne, France.
    26First Department of Paediatrics, Athens University, St. Sophia Children's Hospital, Athens, Greece.
    27Department of Internal Medicine, University Medical Center, Utrecht, Netherlands.
    28Cardiology Clinical Academic Group, Molecular and Clinical Sciences Research Centre, St. Georges University of London, London, United Kingdom.
    Abstract

    The onset and growth of subependymal giant cell astrocytoma (SEGA) in tuberous sclerosis complex (TSC) typically occurs in childhood. There is minimal information on SEGA evolution in adults with TSC. Of 2,211 patients enrolled in TOSCA, 220 of the 803 adults (27.4%) ever had a SEGA. Of 186 patients with SEGA still ongoing in adulthood, 153 (82.3%) remained asymptomatic, and 33 (17.7%) were reported to ever have developed symptoms related to SEGA growth. SEGA growth since the previous scan was reported in 39 of the 186 adults (21%) with ongoing SEGA. All but one patient with growing SEGA had mutations in . Fourteen adults (2.4%) were newly diagnosed with SEGA during follow-up, and majority had mutations in . Our findings suggest that surveillance for new or growing SEGA is warranted also in adulthood, particularly in patients with mutations in .


    KEYWORDS: SEGA, TOSCA, mTOR, registry, tuberous sclerosis complex

    Publikations ID: 31428037
    Quelle: öffnen
     
    Drucken
     
    ccc_logo_en.gif
    ccc_logo_en.gif
    ccc_logo_en.gif

    Schnellinfo

     
    -- Initiative Krebsforschung / Krebsforschungslauf

    -- Cancer Care
    -- Kliniken und Partner
    -- CCC Cancer School
    -- Young CCC
    -- CCC Tumorboards
    -- CCC Forschungscluster
    -- CCC Units
    -- CCC Platforms
    -- SOPs / Leitlinien
    -- Kontakt
    Zuklappen
     
    Ausklappen
     
     

    Featured

     
     
     
     
     
     
     
     
     
     
     
     
     
    © MedUni Wien |
     Impressum | Nutzungsbedingungen | Kontakt